Shuttle Pharmaceuticals Holdings specializes in finding drugs that can sensitize cancers to radiation therapy. They have two products in clinical stages that target brain tumors, soft tissue sarcomas, pancreatic, lung, and liver cancers. Founded in 2012, Shuttle Pharmaceuticals Holdings is based in Rockville, Maryland.